| Autor: |
Schaeffer EM; 1Robert H. Lurie Comprehensive Cancer Center of Northwestern University., Srinivas S; 2Stanford Cancer Institute., Adra N; 3Indiana University Melvin and Bren Simon Comprehensive Cancer Center., An Y; 4Yale Cancer Center/Smilow Cancer Hospital., Bitting R; 5Duke Cancer Institute., Chapin B; 6The University of Texas MD Anderson Cancer Center., Cheng HH; 7Fred Hutchinson Cancer Center., D'Amico AV; 8Dana-Farber/Brigham and Women's Cancer Center., Desai N; 9UT Southwestern Simmons Comprehensive Cancer Center., Dorff T; 10City of Hope National Cancer Center., Eastham JA; 11Memorial Sloan Kettering Cancer Center., Farrington TA; 12Prostate Health Education Network (PHEN)., Gao X; 13Mass General Cancer Center., Gupta S; 14Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Guzzo T; 15Abramson Cancer Center at The University of Pennsylvania., Ippolito JE; 16Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine., Karnes RJ; 17Mayo Clinic Comprehensive Cancer Center., Kuettel MR; 18Roswell Park Comprehensive Cancer Center., Lang JM; 19University of Wisconsin Carbone Cancer Center., Lotan T; 20The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins., McKay RR; 21UC San Diego Moores Cancer Center., Morgan T; 22University of Michigan Rogel Cancer Center., Pow-Sang JM; 23Moffitt Cancer Center., Reiter R; 24UCLA Jonsson Comprehensive Cancer Center., Roach M; 25UCSF Helen Diller Family Comprehensive Cancer Center., Robin T; 26University of Colorado Cancer Center., Rosenfeld S; 27University of California San Francisco Patient Services Committee., Shabsigh A; 28The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Spratt D; 14Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Szmulewitz R; 29The UChicago Medicine Comprehensive Cancer Center., Teply BA; 30Fred & Pamela Buffett Cancer Center., Tward J; 31Huntsman Cancer Institute at the University of Utah., Valicenti R; 32UC Davis Comprehensive Cancer Center., Wong JK; 33Fox Chase Cancer Center., Snedeker J; 34National Comprehensive Cancer Network., Freedman-Cass DA; 34National Comprehensive Cancer Network. |
| Abstrakt: |
The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence. |
